Literature DB >> 12867118

Demographics and concomitant disorders in heart failure.

Henry Krum1, Richard E Gilbert.   

Abstract

Chronic heart failure is an increasingly common cause of premature death and poor quality of life. Community-based epidemiological studies have provided much-needed information on the demography of chronic heart failure, providing insight into its influence on public health. In most patients, chronic heart failure is accompanied by a range of concomitant disorders that both contribute to the cause of the disease and have a key role in its progression and response to treatment. Information on the most common comorbidities in chronic heart failure--ischaemic heart disease, hypertension, and diabetes mellitus--is presented for prespecified subgroups in the reports of many large-scale, multicentre trials; despite their limitations, these subanalyses provide guidance in therapeutic decision-making. Similarly, because chronic heart failure is commonly an endpoint in intervention trials of both hypertension and diabetes, such studies afford important information on the prevention of chronic heart failure in these common diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12867118     DOI: 10.1016/S0140-6736(03)13869-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?

Authors:  Kirkwood F Adams
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 2.  Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment.

Authors:  Paola Terlizzese; Fabrizio Losurdo; Massimo Iacoviello; Nadia Aspromonte
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

Review 3.  Inter-professional team approach to patients with heart failure.

Authors:  Tiny Jaarsma
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 4.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.

Authors:  D Kent Arrell; Jelena Zlatkovic Lindor; Satsuki Yamada; Andre Terzic
Journal:  Cardiovasc Res       Date:  2011-02-14       Impact factor: 10.787

5.  Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data.

Authors:  Gillian E Caughey; Elizabeth E Roughead; Sepehr Shakib; Agnes I Vitry; Andrew L Gilbert
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

Review 6.  Palliative care for end-stage heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Heart Fail Rep       Date:  2005-09

7.  N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders.

Authors:  G Hess; J Moecks; D Zdunek
Journal:  Z Kardiol       Date:  2005-04

8.  The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.

Authors:  Bernhard Straubhaar; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

9.  Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?

Authors:  Daniela Dobre; Mike J L DeJongste; Carolien Lucas; Ger Cleuren; Dirk J van Veldhuisen; Adelita V Ranchor; Flora Haaijer-Ruskamp
Journal:  Br J Clin Pharmacol       Date:  2006-09-12       Impact factor: 4.335

Review 10.  Is heart failure different on the two continents (North America and Europe)?

Authors:  Rachel Hughes-Doichev; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.